Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET - PubMed (original) (raw)

. 2010 Nov;51(11):1763-70.

doi: 10.2967/jnumed.109.074021. Epub 2010 Oct 18.

Affiliations

• PMID: 20956470
• DOI: 10.2967/jnumed.109.074021

Free article

Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET

Anders Ettrup et al. J Nucl Med. 2010 Nov.

Free article

Abstract

PET brain imaging of the serotonin 2A (5-hydroxytryptamine 2A, or 5-HT(2A)) receptor has been widely used in clinical studies, and currently, several well-validated radiolabeled antagonist tracers are used for in vivo imaging of the cerebral 5-HT(2A) receptor. Access to 5-HT(2A) receptor agonist PET tracers would, however, enable imaging of the active, high-affinity state of receptors, which may provide a more meaningful assessment of membrane-bound receptors. In this study, we radiolabel the high-affinity 5-HT(2A) receptor agonist 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-[(11)C-OCH(3)]methoxybenzyl)ethanamine ((11)C-CIMBI-5) and investigate its potential as a PET tracer.

Methods: The in vitro binding and activation at 5-HT(2A) receptors by CIMBI-5 was measured with binding and phosphoinositide hydrolysis assays. Ex vivo brain distribution of (11)C-CIMBI-5 was investigated in rats, and PET with (11)C-CIMBI-5 was conducted in pigs.

Results: In vitro assays showed that CIMBI-5 was a high-affinity agonist at the 5-HT(2A) receptor. After intravenous injections of (11)C-CIMBI-5, ex vivo rat studies showed a specific binding ratio of 0.77 ± 0.07 in the frontal cortex, which was reduced to cerebellar levels after ketanserin treatment, thus indicating that (11)C-CIMBI-5 binds selectively to the 5-HT(2A) receptor in the rat brain. The PET studies showed that the binding pattern of (11)C-CIMBI-5 in the pig brain was in accordance with the expected 5-HT(2A) receptor distribution. (11)C-CIMBI-5 gave rise to a cortical binding potential of 0.46 ± 0.12, and the target-to-background ratio was similar to that of the widely used 5-HT(2A) receptor antagonist PET tracer (18)F-altanserin. Ketanserin treatment reduced the cortical binding potentials to cerebellar levels, indicating that in vivo (11)C-CIMBI-5 binds selectively to the 5-HT(2A) receptor in the pig brain.

Conclusion: (11)C-CIMBI-5 showed a cortex-to-cerebellum binding ratio equal to the widely used 5-HT(2A) antagonist PET tracer (18)F-altanserin, indicating that (11)C-CIMBI-5 has a sufficient target-to-background ratio for future clinical use and is displaceable by ketanserin in both rats and pigs. Thus, (11)C-CIMBI-5 is a promising tool for investigation of 5-HT(2A) agonist binding in the living human brain.

PubMed Disclaimer

Similar articles

• Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.
  Ettrup A, Hansen M, Santini MA, Paine J, Gillings N, Palner M, Lehel S, Herth MM, Madsen J, Kristensen J, Begtrup M, Knudsen GM. Ettrup A, et al. Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):681-93. doi: 10.1007/s00259-010-1686-8. Epub 2010 Dec 21. Eur J Nucl Med Mol Imaging. 2011. PMID: 21174090
• Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.
  Finnema SJ, Stepanov V, Ettrup A, Nakao R, Amini N, Svedberg M, Lehmann C, Hansen M, Knudsen GM, Halldin C. Finnema SJ, et al. Neuroimage. 2014 Jan 1;84:342-53. doi: 10.1016/j.neuroimage.2013.08.035. Epub 2013 Aug 28. Neuroimage. 2014. PMID: 23994452
• Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
  Ettrup A, Svarer C, McMahon B, da Cunha-Bang S, Lehel S, Møller K, Dyssegaard A, Ganz M, Beliveau V, Jørgensen LM, Gillings N, Knudsen GM. Ettrup A, et al. Neuroimage. 2016 Apr 15;130:167-174. doi: 10.1016/j.neuroimage.2016.02.001. Epub 2016 Feb 11. Neuroimage. 2016. PMID: 26876490
• 2-(4-Bromo-2,5-dimethoxyphenyl)-_N_-(2-[11C]methoxybenzyl)ethanamine.
  Leung K. Leung K. 2011 Feb 18 [updated 2011 Mar 30]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2011 Feb 18 [updated 2011 Mar 30]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21473029 Free Books & Documents. Review.
• 2-(4-Iodo-2,5-dimethoxyphenyl)-_N_-(2-[11C]methoxybenzyl)ethanamine.
  Leung K. Leung K. 2011 Jan 18 [updated 2011 Mar 23]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2011 Jan 18 [updated 2011 Mar 23]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21473027 Free Books & Documents. Review.

Cited by

• Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.
  Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C. Cumming P, et al. Molecules. 2021 Apr 22;26(9):2451. doi: 10.3390/molecules26092451. Molecules. 2021. PMID: 33922330 Free PMC article. Review.
• Psychedelics.
  Nichols DE. Nichols DE. Pharmacol Rev. 2016 Apr;68(2):264-355. doi: 10.1124/pr.115.011478. Pharmacol Rev. 2016. PMID: 26841800 Free PMC article. Review.
• Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?
  Colom M, Vidal B, Zimmer L. Colom M, et al. Front Mol Neurosci. 2019 Oct 18;12:255. doi: 10.3389/fnmol.2019.00255. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31680859 Free PMC article. Review.
• NBOMes-Highly Potent and Toxic Alternatives of LSD.
  Zawilska JB, Kacela M, Adamowicz P. Zawilska JB, et al. Front Neurosci. 2020 Feb 26;14:78. doi: 10.3389/fnins.2020.00078. eCollection 2020. Front Neurosci. 2020. PMID: 32174803 Free PMC article. Review.
• 5-HT radioligands for human brain imaging with PET and SPECT.
  Paterson LM, Kornum BR, Nutt DJ, Pike VW, Knudsen GM. Paterson LM, et al. Med Res Rev. 2013 Jan;33(1):54-111. doi: 10.1002/med.20245. Epub 2011 Jun 14. Med Res Rev. 2013. PMID: 21674551 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • HighWire